It is appropriate to develop National Strategy to provide a common framework to enhance response to ATS use and to coordinate activities to prevent use and respond to harms at national and jurisdictional levels. The National Strategy will be developed through a process involving a thorough review of the evidence and broad stakeholder consultation. The National Strategy will address supply, demand and harm reduction, and consequently will be consistent with the National Drug Strategy 2004-2009. The nature of ATS use and related harm dictates that the Strategy will address health and law enforcement issues.